Sensitivity of synthetic surfactants to albumin inhibition in preterm rabbits

Molecular Genetics and Metabolism

Volumn 66, Issue 1, 1999, Pages 40-48

  Mbagwu, Nneamaka ^a   Bruni, Roberta ^a,b   Hernández Juviel, José M ^b   Waring, Alan J ^a,b   Walther, Frans J ^a,b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Lung function; Respiratory distress syndrome; Surface activity; Surfactant; Surfactant inhibition; Surfactant peptides

Indexed keywords

HUMAN ALBUMIN; LUNG SURFACTANT; PALMITIC ACID; PHOSPHOLIPID; PLACEBO; SYNTHETIC PEPTIDE;

ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; INTRATRACHEAL DRUG ADMINISTRATION; LUNG COMPLIANCE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NONHUMAN; PEPTIDE SYNTHESIS; PREMATURITY; PRIORITY JOURNAL; RABBIT; RESPIRATORY DISTRESS SYNDROME;

ANIMALIA; ORYCTOLAGUS CUNICULUS; UCLA;

EID: 0032813644     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1998.2788     Document Type: Article

References (43)

1. Nogee LM, Gamier G, Dietz HC, Singer L, Murphy AM, deMello DE, Colten HR. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 93:1860-1863, 1994.
2. Robertson B, Kobayashi T, Ganzuka M, Grossmann G, Li WZ, Suzuki Y. Experimental neonatal respiratory failure induced by a monoclonal antibody to the hydrophobic surfactant-associated protein SP-B. Pediatr Res 30:239-43, 1991.
3. Berry D, Ikegami M, Jobe A.Respiratory distress and surfactant inhibition following vagotomy in rabbits. J Appl Physiol 61:1741-8, 1986.
4. Ikegami M, Agata Y, Elkady T, Hallman M, Berry D, Jobe A. Comparison of four surfactants: In vitro surface properties and responses of preterm lambs to treatment at birth. Pediatrics 79:38-46, 1987.
5. Kobayashi T, Nitta K, Ganzuka M, Inui S, Grossmann G, Robertson B. Inactivation of exogenous surfactant by pulmonary edema fluid. Pediatr Res 29:353-356, 1991.
6. Nitta K, Kobayashi T. Impairment of surfactant activity and ventilation by proteins in lung edema fluid. Respir Physiol 95:43-51, 1994.
7. Holm BA, Notter RH, Finkelstein JN. Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids. Chem Phys Lipids 38: 287-298, 1985.
8. Fuuchimukai T, Fuchiwara T, Takahashi A, Enhorning G. Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 62:429-437, 1987.
9. Keough KMW, Parsons CS, Tweeddale MG. Interactions between plasma proteins and pulmonary surfactant: Surface balance studies. Can J Physiol Pharmacol 66:1166-1173, 1988.
10. Keough KMW, Parsons CS, Tweeddale MG. Interactions between plasma proteins and pulmonary surfactant: Pulsating bubble studies. Can J Physiol Pharmacol 67:663-668, 1989.
11. Seeger W, Grube C, Günther A, Schmidt R. Surfactant inhibition by plasma proteins: Differential sensitivity of various surfactant preparations. Eur Respir J 6:971-977, 1993.
12. Holm BA, Enhorning G, Notter RH. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids 49:49-55, 1988.
13. Holm BA, Notter RH. Effects of hemoglobin and cell membrane lipids on surfactant activity. J Appl Physiol 63:1434-1442, 1987.
14. McEachren TM, Keough KMW. Phosphocholine reverses inhibition of pulmonary surfactant adsorption caused by C-reactive protein. Am J Physiol 269:L492-L497, 1995.
15. Seeger W, Stöhr G, Wolf HRD, Neuhof H. Alteration of surfactant function due to protein leakage: Special interaction with fibrin monomer. J Appl Physiol 58:326-338, 1985.
16. 4. Pediatr Res 39:947-952, 1996.
17. Seeger W, Thede C, Gunther A, Grube C. Surface properties and sensitivity to protein-inhibition of a recombinant apo-protein C-based phospholipid mixture in vitro - Comparison to natural surfactant. Biochim Biophys Acta 1081:45-52, 1991.
18. Cochrane CG, Revak SD. Pulmonary surfactant protein B (SP-B): Structure-function relationships. Science 254:566-568, 1991.
19. Amirkhanian JD, Bruni R, Waring AJ, Navar C, Taeusch HW. Full length synthetic surfactant proteins, SP-B and SP-C, reduce surfactant inactivation by serum. Biochim Biophys Acta 1168:315-320, 1993.
20. Amirkhanian JD, Bruni R, Waring AJ, Taeusch HW. Inhibition of mixtures of surfactant lipids and synthetic sequences of surfactant proteins SP-B and SP-C. Biochim Biophys Acta 1096:355-360, 1991.
21. Fields CG, Loyd DH, McDonald RL, Ottenson KM, Nobel RL. HBTU activation for automated Fmoc solid-phase peptide synthesis. Peptide Res 4:95-101, 1991.
22. Lipp MM, Lee KYC, Zasadzinski JA, Waring AJ. Phase and morphology changes in lipid monolayers induced by SP-B protein and its amino terminal peptide. Science 273:1196-1199, 1996.
23. Walther FJ, Hernandez-Juviel J, Bruni R, Waring AJ. Spiking Survanta with synthetic surfactant peptides improves oxygenation in surfactant-deficient rats. Am J Resp Crit Care Med 156:855-861, 1997.
24. Walther FJ, Hernandez-Juviel J, Bruni R, Waring AJ. Protein composition of synthetic surfactant affects gas exchange in surfactant-deficient rats. Pediatr Res 43:666-673, 1998.
25. Ballard PL, Nogee LM, Beers MF, Ballard RA, Planer BC, Polk L, deMello DE, Moxley MA, Longmore WJ. Partial deficiency of surfactant protein B in an infant with chronic lung disease. Pediatrics 96:1046-1052, 1995.
26. Revak SD, Merritt TA, Hallman M, Heldt G, La Polla RJ, Hoey K, Houghten RA, Cochrane CG. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants. Pediatr Res 29:460-465, 1991.
27. Oosterlaken-Dijksterhuis MA, Haagsman HP, van Golde LMG, Demel RA. Characterization of lipid insertion into monomolecular mediated layers by lung surfactant proteins SP-B and SP-C. Biochemistry 30:10965-10971, 1991.
28. Kobayashi T, Tashiro K, Yamamoto K, Nitta S, Ohmura S, Suzuki Y. Effects of surfactant proteins SP-B and SP-C on dynamic and static mechanics of immature lungs. J Appl Physiol 83:1849-1856, 1997.
29. Böhlen P, Stein S, Dairman W, Udenfriend S. Fluorimetric assay of proteins in nanogram range. Arch Biochem Biophys 155:213-220, 1973.
30. Longo ML, Bisagno AM, Zasadzinski JAN, Bruni R, Waring AJ. The function of lung surfactant protein SP-B. Science 261:453-456, 1993.
31. Walther FJ, David-Cu R, Leung C, Bruni R, Hernandez-Juviel J, Gordon LM, Waring AJ. A synthetic segment of surfactant protein A: structure, in vitro surface activity, and in vivo efficacy. Pediatr Res 39:938-946, 1996.
32. Ikegami M, Berry D, Elkady T, Pettenazzo A, Seidner S, Jobe A. Corticosteroids and surfactant change lung function and protein leaks in the lungs of ventilated premature rabbits. J Clin Invest 79:1371-1378, 1987.
33. Markwell MA, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determinations in membrane and lipoprotein samples. Anal Biochem 87:206-210, 1978.
34. Knells G, Ahmed MK, Das RM, Oulton MR, Mantsch HH, Scott JE. Fourier-transform infrared spectroscopic analysis of rabbit lung surfactant: Subfraction-associated phospholipid and protein profiles. Chem Phys Lipids 77:193-201, 1995.
35. Walther FJ, David-Cu R, Lopez SL. Antioxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits. Am J Physiol 269:L613-L617, 1995.
36. Hallman M, Gluck L. Formation of acidic phospholipids in rabbit lung during perinatal development. Pediatr Res 14: 1250-1259, 1980.
37. Hallman M. Fetal development of surfactant: considerations phosphatidylcholine, phosphatidylinositol, and phosphatidylglycerol formation. Prog Respir Res 15:27-40, 1981.
38. Seidner SR, Ikegami M, Yamada T, Rider ED, Castro R, Jobe AH. Decreased surfactant dose-response after delayed administration to preterm rabbits. Am J Respir Crit Care Med 152:113-120, 1995.
39. Sarin VK, Gupta S, Leung TK, Taylor VE, Ohning BL, Whitsett JA, Fox JL. Biophysical and biological activity of a synthetic 8.7-kDa hydrophobic pulmonary surfactant protein SP-B. Proc Natl Acad Sci USA 87:2633-2637, 1990.
40. Gordon LM, Horvath S, Longo ML, Zasadzinski JA, Taeusch HW, Faull K, Leung C, Waring AJ. Conformation and molecular topography of the N-terminal segment of surfactant protein B in structure-promoting environments. Protein Sci 5:1662-1675, 1996.
41. Waring AJ, Faull KF, Leung C, Chang-Chien A, Mercado P, Taeusch HW, Gordon LM. Synthesis, secondary structure and folding of the bend region of lung surfactant protein B. Peptide Res 9:28-39, 1996.
42. 4) is a transmembrane a-helix with a mixed nonpolar/polar surface. FEBS Lett 384:185-188, 1996.
43. Bruni R, Hernandez-Juviel J, Waring AJ, Walther FJ. Is in vitro surface activity a reliable indicator of in vivo surfactant function? J Invest Med 45:130A, 1997.